AR054745A1 - Proceso para la preparacion de moduladores opioides - Google Patents
Proceso para la preparacion de moduladores opioidesInfo
- Publication number
- AR054745A1 AR054745A1 ARP060100973A ARP060100973A AR054745A1 AR 054745 A1 AR054745 A1 AR 054745A1 AR P060100973 A ARP060100973 A AR P060100973A AR P060100973 A ARP060100973 A AR P060100973A AR 054745 A1 AR054745 A1 AR 054745A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- give
- reacting
- corresponding compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/14—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Optical Modulation, Optical Deflection, Nonlinear Optics, Optical Demodulation, Optical Logic Elements (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Reivindicacion 1: Un proceso para la preparacion de un compuesto de formula (1) en la cual el anillo P es arilo C6-10 o un heteroarilo seleccionado del grupo integrado por furilo, tienilo, pirrolilo, oxazolilo, tiazolilo, imidazolilo, pirazolilo, piridinilo, pirimidinilo, pirazinilo, indolilo, isoindolilo, indolinilo, benzofurilo, benzotienilo, bencimidazolilo, benzotiazolilo, benzoxazolilo, quinolizinilo, quinolinilo, isoquinolinilo y quinazolinilo; cada R41p se selecciona independientemente de alquilo C1-6, alcoxi C1-6 o F; RJ y RK se seleccionan cada uno independientemente de H o alquilo C1-4; en forma alternativa, RJ y RK se toman junto con el átomo de N al cual están unidos para formar un heterociclilo de 5 a 7 miembros; Pg1 es un grupo protector de N; que comprende hacer reaccionar un compuesto de formula (2), en la cual Xp se selecciona de OH, CN, -CO2H, -C(O)-CL o -C(O)-Oalquilo C1-4 y en la cual Yp se selecciona de Br, Cl, o I, para dar el compuesto correspondiente de formula (3); hacer reaccionar el compuesto de formula (3) con un compuesto sustituido en forma adecuada de formula (4); en presencia de un catalizador de paladio; en presencia de una base orgánica o inorgánica; en un solvente orgánico; a una temperatura superior aproximadamente la temperatura ambiente; para dar el compuesto correspondiente de formula (5); hacer reaccionar el compuesto de formula (5) con H o una fuente de H, en presencia de un catalizador; en un solvente, a una temperatura superior a aproximadamente la temperatura ambiente; para dar el compuesto correspondiente de formula (6); hacer reaccionar el compuesto de formula (6) con una base acuosa; en un solvente orgánico, para dar el compuesto correspondiente de formula (1).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66178405P | 2005-03-14 | 2005-03-14 | |
| US11/368,588 US20060211861A1 (en) | 2005-03-14 | 2006-03-06 | Process for the preparation of opioid modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR054745A1 true AR054745A1 (es) | 2007-07-11 |
Family
ID=36646011
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060100973A AR054745A1 (es) | 2005-03-14 | 2006-03-14 | Proceso para la preparacion de moduladores opioides |
| ARP060100974A AR053170A1 (es) | 2005-03-14 | 2006-03-14 | Proceso para la preparacion de moduladores de receptores opioides e intermediarios en su sintesis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060100974A AR053170A1 (es) | 2005-03-14 | 2006-03-14 | Proceso para la preparacion de moduladores de receptores opioides e intermediarios en su sintesis |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US20060211861A1 (es) |
| EP (2) | EP1858850B1 (es) |
| JP (3) | JP2008533141A (es) |
| KR (2) | KR101280929B1 (es) |
| CN (2) | CN101175725B (es) |
| AR (2) | AR054745A1 (es) |
| AU (2) | AU2006223482A1 (es) |
| BR (2) | BRPI0607792A2 (es) |
| CA (2) | CA2601481C (es) |
| CR (1) | CR9438A (es) |
| CY (1) | CY1116104T1 (es) |
| DK (1) | DK1858850T3 (es) |
| EA (2) | EA014366B1 (es) |
| ES (1) | ES2535048T3 (es) |
| HR (1) | HRP20150417T1 (es) |
| HU (1) | HUE024912T2 (es) |
| IL (3) | IL185974A0 (es) |
| ME (1) | ME02110B (es) |
| MX (2) | MX2007011412A (es) |
| MY (1) | MY145333A (es) |
| NI (1) | NI200700237A (es) |
| NO (2) | NO20075268L (es) |
| NZ (1) | NZ590570A (es) |
| PL (1) | PL1858850T3 (es) |
| PT (1) | PT1858850E (es) |
| RS (1) | RS53873B1 (es) |
| SI (1) | SI1858850T1 (es) |
| TW (3) | TWI414518B (es) |
| WO (2) | WO2006099060A2 (es) |
| ZA (2) | ZA200708809B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7041681B2 (en) * | 2002-04-29 | 2006-05-09 | Janssen Pharmaceutica N.V. | Compounds as opioid receptor modulators |
| CN1950342B (zh) * | 2004-03-15 | 2012-09-26 | 詹森药业有限公司 | 作为阿片受体调节剂的新化合物 |
| DK1858850T3 (en) * | 2005-03-14 | 2015-02-09 | Janssen Pharmaceutica Nv | PROCEDURE FOR THE MANUFACTURING OF OPIOID MODULATORS |
| UA104713C2 (ru) * | 2007-07-09 | 2014-03-11 | Фуриекс Фармасьютикалз, Инк. | Кристаллы и способ получения 5-({[2-амино-3-(4-карбамоил-2,6-диметилфенил)-пропионил]-[1-(4-фенил-1h-имидазол-2-ил)-этил]-амино}-метил)-метоксибензойной кислоты |
| TWI468375B (zh) * | 2008-10-27 | 2015-01-11 | Janssen Pharmaceutica Nv | 製備經保護之ｌ－丙胺酸衍生物之方法 |
| IS2977B (is) | 2015-02-23 | 2017-07-15 | Actavis Group Ptc Ehf. | Aðferð til framleiðslu á milliefnum sem eru nytsamleg við nýsmíði á elúxadólíni |
| CN108026032B (zh) * | 2015-09-11 | 2020-09-29 | 株式会社钟化 | 光学活性4-氨基甲酰基-2,6-二甲基苯基丙氨酸衍生物的制造方法 |
| CN105777584B (zh) * | 2016-03-28 | 2018-01-02 | 成都伊诺达博医药科技有限公司 | 丙氨酸衍生物的制备方法 |
| CN105693554B (zh) * | 2016-04-06 | 2017-08-08 | 成都伊诺达博医药科技有限公司 | 丙氨酸衍生物的制备方法 |
| US10822308B2 (en) * | 2016-06-23 | 2020-11-03 | Sun Pharmaceutical Industries Limited | Processes for the preparation of eluxadoline |
| WO2018047131A1 (en) * | 2016-09-09 | 2018-03-15 | Sun Pharmaceutical Industries Limited | Amorphous eluxadoline |
| WO2018055528A2 (en) | 2016-09-20 | 2018-03-29 | Sun Pharmaceutical Industries Limited | Processes for the preparation of eluxadoline |
| CN106866463B (zh) * | 2017-01-24 | 2018-08-28 | 富乐马鸿凯（大连）医药有限公司 | 艾沙度林中间体的制备方法 |
| WO2018138272A1 (en) | 2017-01-27 | 2018-08-02 | Quimica Sintetica, S. A. | Eluxadoline crystalline form and process for the preparation thereof |
| US10738013B2 (en) | 2017-01-27 | 2020-08-11 | Quimica Sintetica, S.A. | Eluxadoline crystalline forms and processes for their preparation |
| CN111377832A (zh) * | 2018-12-27 | 2020-07-07 | 江苏联昇化学有限公司 | 一种伊卢多啉中间体制备的新方法 |
| CN115298173A (zh) | 2020-03-31 | 2022-11-04 | 田边三菱制药株式会社 | 羟基吡咯烷衍生物及其医药用途 |
| CN114163348A (zh) * | 2020-11-27 | 2022-03-11 | 成都泰蓉生物科技有限公司 | 一种氨酰基取代的l-苯丙氨酸的合成方法 |
| CN114507252B (zh) * | 2022-02-21 | 2023-10-27 | 广西大学 | 新型芳基硅烷化合物的合成方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5430129A (en) * | 1977-08-09 | 1979-03-06 | Mitsubishi Gas Chem Co Inc | Preparation of toluic acid amide |
| JPS5528959A (en) * | 1978-08-22 | 1980-02-29 | Sumitomo Chem Co Ltd | Production of amide derivative |
| FR2584401B1 (fr) * | 1985-07-04 | 1987-11-20 | Ile De France | Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique |
| JP2727243B2 (ja) * | 1988-12-27 | 1998-03-11 | 日本化薬株式会社 | ２−アシルアミノ桂皮酸誘導体の製造法 |
| US5684175A (en) * | 1993-02-05 | 1997-11-04 | Napro Biotherapeutics, Inc. | C-2' hydroxyl-benzyl protected, N-carbamate protected (2R, 3S)- 3-phenylisoserine and production process therefor |
| JP3493206B2 (ja) * | 1993-03-19 | 2004-02-03 | ダイセル化学工業株式会社 | 光学活性β−アミノ酸類の製法 |
| JP3486922B2 (ja) * | 1993-08-23 | 2004-01-13 | 住友化学工業株式会社 | 酸アミドの製造法 |
| WO1996022997A1 (en) * | 1995-01-27 | 1996-08-01 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| JPH09295939A (ja) * | 1995-09-26 | 1997-11-18 | Takeda Chem Ind Ltd | リン酸アミド誘導体、その製造法および用途 |
| CA2322873A1 (en) * | 1998-03-11 | 1999-09-16 | G.D. Searle & Co. | Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| ES2206139T3 (es) * | 1999-05-28 | 2004-05-16 | Pfizer Products Inc. | Derivados de 3-(3-hidrofenil)-3-amino-propionamida. |
| NZ525928A (en) * | 2000-10-30 | 2005-06-24 | Janssen Pharmaceutica Nv | Tripeptidyl peptidase inhibitors |
| US7041681B2 (en) * | 2002-04-29 | 2006-05-09 | Janssen Pharmaceutica N.V. | Compounds as opioid receptor modulators |
| CN1950342B (zh) * | 2004-03-15 | 2012-09-26 | 詹森药业有限公司 | 作为阿片受体调节剂的新化合物 |
| DK1858850T3 (en) * | 2005-03-14 | 2015-02-09 | Janssen Pharmaceutica Nv | PROCEDURE FOR THE MANUFACTURING OF OPIOID MODULATORS |
-
2006
- 2006-03-06 DK DK06737611.1T patent/DK1858850T3/en active
- 2006-03-06 JP JP2008501912A patent/JP2008533141A/ja not_active Withdrawn
- 2006-03-06 RS RS20150121A patent/RS53873B1/sr unknown
- 2006-03-06 EP EP06737611.1A patent/EP1858850B1/en active Active
- 2006-03-06 EP EP06737413A patent/EP1863764A1/en not_active Withdrawn
- 2006-03-06 CA CA2601481A patent/CA2601481C/en active Active
- 2006-03-06 PL PL06737611T patent/PL1858850T3/pl unknown
- 2006-03-06 MX MX2007011412A patent/MX2007011412A/es active IP Right Grant
- 2006-03-06 BR BRPI0607792-7A patent/BRPI0607792A2/pt not_active IP Right Cessation
- 2006-03-06 HR HRP20150417TT patent/HRP20150417T1/hr unknown
- 2006-03-06 CA CA002601674A patent/CA2601674A1/en not_active Abandoned
- 2006-03-06 NZ NZ590570A patent/NZ590570A/en not_active IP Right Cessation
- 2006-03-06 EA EA200701979A patent/EA014366B1/ru not_active IP Right Cessation
- 2006-03-06 MX MX2007011409A patent/MX2007011409A/es unknown
- 2006-03-06 HU HUE06737611A patent/HUE024912T2/en unknown
- 2006-03-06 EA EA200701978A patent/EA015512B1/ru unknown
- 2006-03-06 US US11/368,588 patent/US20060211861A1/en not_active Abandoned
- 2006-03-06 PT PT67376111T patent/PT1858850E/pt unknown
- 2006-03-06 KR KR1020077022664A patent/KR101280929B1/ko not_active Expired - Fee Related
- 2006-03-06 AU AU2006223482A patent/AU2006223482A1/en not_active Abandoned
- 2006-03-06 BR BRPI0607793-5A patent/BRPI0607793A2/pt not_active Application Discontinuation
- 2006-03-06 WO PCT/US2006/008450 patent/WO2006099060A2/en not_active Ceased
- 2006-03-06 JP JP2008501919A patent/JP5384933B2/ja not_active Expired - Fee Related
- 2006-03-06 US US11/368,564 patent/US7629488B2/en active Active
- 2006-03-06 ME MEP-2015-31A patent/ME02110B/me unknown
- 2006-03-06 ES ES06737611.1T patent/ES2535048T3/es active Active
- 2006-03-06 WO PCT/US2006/008240 patent/WO2006098982A1/en not_active Ceased
- 2006-03-06 CN CN2006800163712A patent/CN101175725B/zh not_active Expired - Fee Related
- 2006-03-06 SI SI200631907T patent/SI1858850T1/sl unknown
- 2006-03-06 AU AU2006223394A patent/AU2006223394B2/en not_active Ceased
- 2006-03-06 KR KR1020077023282A patent/KR20070112255A/ko not_active Ceased
- 2006-03-06 CN CNA2006800166320A patent/CN101175726A/zh active Pending
- 2006-03-14 AR ARP060100973A patent/AR054745A1/es active IP Right Grant
- 2006-03-14 TW TW095108512A patent/TWI414518B/zh not_active IP Right Cessation
- 2006-03-14 MY MYPI20061110A patent/MY145333A/en unknown
- 2006-03-14 TW TW101129655A patent/TWI500595B/zh not_active IP Right Cessation
- 2006-03-14 AR ARP060100974A patent/AR053170A1/es not_active Application Discontinuation
- 2006-03-14 TW TW095108513A patent/TW200700388A/zh unknown
-
2007
- 2007-09-13 NI NI200700237A patent/NI200700237A/es unknown
- 2007-09-16 IL IL185974A patent/IL185974A0/en unknown
- 2007-09-16 IL IL185972A patent/IL185972A/en active IP Right Grant
- 2007-10-12 ZA ZA200708809A patent/ZA200708809B/xx unknown
- 2007-10-12 CR CR9438A patent/CR9438A/es not_active Application Discontinuation
- 2007-10-12 ZA ZA200708810A patent/ZA200708810B/xx unknown
- 2007-10-15 NO NO20075268A patent/NO20075268L/no not_active Application Discontinuation
- 2007-10-15 NO NO20075269A patent/NO340604B1/no not_active IP Right Cessation
-
2009
- 2009-10-16 US US12/580,641 patent/US20100036132A1/en not_active Abandoned
- 2009-11-25 US US12/625,973 patent/US20100152460A1/en not_active Abandoned
-
2010
- 2010-11-18 IL IL209402A patent/IL209402A/en active IP Right Grant
-
2013
- 2013-07-16 JP JP2013147688A patent/JP5802242B2/ja not_active Expired - Fee Related
-
2015
- 2015-02-19 CY CY20151100172T patent/CY1116104T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR054745A1 (es) | Proceso para la preparacion de moduladores opioides | |
| AR063142A1 (es) | Derivados de 2-(bencimidazolil) purina y purinonas 6-sustituidas utiles como inmunosupresores,y composiciones farmaceuticas que los contienen. | |
| CO5570669A2 (es) | Pirazolopirimidinas como agentes terapeuticos | |
| AR090328A1 (es) | Pirrolidina-2-carboxamidas sustituidas | |
| CO6150158A2 (es) | Piperidinas sustituidas que aumentan la actividad de p53 y su uso | |
| PE20130375A1 (es) | Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos | |
| SV2007002160A (es) | Inhibidores de cetp ref. b.16744/shh | |
| CO6231002A2 (es) | Compuestos utiles como ligandos para tomar imagenes de inervacion cardiaca | |
| CO6251241A2 (es) | Compuestos de prolina modificados con actividad anti-vhc | |
| CO6160312A2 (es) | Derivados de quiniclidina de acido (hetero) arilcicloheptano carboxilico como antagonistas del receptor muscarinico | |
| PE20060855A1 (es) | Derivados de carboxamida biciclicos fusionados como inhibidores de cxcr2 | |
| AR026990A1 (es) | Antagonistas de neurokinina selectivos | |
| DE60038185D1 (de) | Arly- und heteroaryl-substituierte tetrahydroisoquinoline und ihre verwendung als hemmer der wiederaufnahme von norepinephrin, dopamin und serotonin | |
| AR083543A1 (es) | Diamidas de amino-pirrolidin-azetidinas, composiciones farmaceuticas que las contienen y uso de las mismas para tratar dolores inflamatorios | |
| AR112338A2 (es) | Arilciclohexiléteres de dihidro-tetraazabenzoazuleno | |
| AR060621A1 (es) | Compuestos triarilicos y sus derivados | |
| AR049401A1 (es) | Aza-biciclononanos | |
| HRP20180176T1 (hr) | Spojevi korisni u sintezi spojeva benzamida | |
| EA201391094A1 (ru) | Антагонисты рецепторов trpm8 | |
| EA200971044A1 (ru) | Арил- и гетероарилзамещенные тетрагидробензо-1,4-диазепины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина | |
| PE20081834A1 (es) | Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos | |
| AR058885A1 (es) | Compuestos de piperidina 3,5-sustituidos | |
| AR094122A1 (es) | Compuestos triciclicos moduladores de la actividad de cftr | |
| AR094123A1 (es) | Compuesto triciclicos | |
| AR035728A1 (es) | Proceso perfeccionado para la sintesis de carbapenem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |